148 related articles for article (PubMed ID: 3925762)
21. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry M; Ferguson RM
Transplantation; 1987 Jan; 43(1):85-90. PubMed ID: 3541330
[TBL] [Abstract][Full Text] [Related]
22. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
Maddux MS; Veremis SA; Pollak R; Mozes MF
Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
[TBL] [Abstract][Full Text] [Related]
23. Impact of cyclosporine on renal transplant practice at the University of Texas Medical School at Houston.
Kahan BD; Kerman RH; Wideman CA; Flechner SM; Jarowenko M; Van Buren CT
Am J Kidney Dis; 1985 Jun; 5(6):288-95. PubMed ID: 3925760
[TBL] [Abstract][Full Text] [Related]
24. Experience with cyclosporine and steroids in clinical renal transplantation.
Tilney NL; Milford EL; Araujo JL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1984 Nov; 200(5):605-13. PubMed ID: 6385881
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
Martin DC; Tertzakian G; Ruzics E
J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
[TBL] [Abstract][Full Text] [Related]
26. Reversibility of cyclosporin nephrotoxicity after three months' treatment.
Chapman JR; Griffiths D; Harding NG; Morris PJ
Lancet; 1985 Jan; 1(8421):128-30. PubMed ID: 2857212
[TBL] [Abstract][Full Text] [Related]
27. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
[TBL] [Abstract][Full Text] [Related]
28. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine: five years' experience in cadaveric renal transplantation.
Merion RM; White DJ; Thiru S; Evans DB; Calne RY
N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
[TBL] [Abstract][Full Text] [Related]
30. Modifying cyclosporine associated renal allograft dysfunction.
Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
[TBL] [Abstract][Full Text] [Related]
31. Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients.
Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
Transplantation; 1987 Jan; 43(1):65-70. PubMed ID: 3541326
[TBL] [Abstract][Full Text] [Related]
32. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
[No Abstract] [Full Text] [Related]
33. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
34. The adverse impact of cytomegalovirus infection on clinical outcome in cyclosporine-prednisone treated renal allograft recipients.
Lewis RM; Johnson PC; Golden D; Van Buren CT; Kerman RH; Kahan BD
Transplantation; 1988 Feb; 45(2):353-9. PubMed ID: 2830686
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
[No Abstract] [Full Text] [Related]
36. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
[TBL] [Abstract][Full Text] [Related]
37. Allograft renal vascular thrombosis--lack of increase with cyclosporine immunosuppression.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplantation; 1989 Mar; 47(3):475-8. PubMed ID: 2646779
[TBL] [Abstract][Full Text] [Related]
38. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years.
Canadian Multicentre Transplant Study Group
N Engl J Med; 1986 May; 314(19):1219-25. PubMed ID: 2871486
[TBL] [Abstract][Full Text] [Related]
39. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
[No Abstract] [Full Text] [Related]
40. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
